InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

Current share price for NTI : $0.015 0.001 (3.57%)+

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Notification regarding unquoted securities - NTI 13 Dec 2021 6:31PM $0.058 $0.015 fallen by 75%
$23 Notification regarding unquoted securities - NTI 13 Dec 2021 6:27PM $0.058 $0.015 fallen by 75%
$23 Preclinical Success with Targeted Combination Therapies 1 Dec 2021 9:00AM $0.059 $0.015 fallen by 75.42%
$23 Results of Meeting 18 Nov 2021 7:25PM $0.070 $0.015 fallen by 79.29%
$23 Application for quotation of securities - NTI 16 Nov 2021 5:37PM $0.072 $0.015 fallen by 79.86%
$23 Change of Director's Interest Notice 8 Nov 2021 6:02PM $0.065 $0.015 fallen by 77.69%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2021 9:17AM $0.056 $0.015 fallen by 74.11%
$23 Investor Presentation 25 Oct 2021 9:23AM $0.050 $0.015 fallen by 71%
$23 NTI to Present at the South-West Connect ASX Showcase 25 Oct 2021 9:18AM $0.050 $0.015 fallen by 71%
$23 Successful Completion of Preclinical MS Studies 22 Oct 2021 9:50AM $0.046 $0.015 fallen by 68.48%
$23 Annual Report (Typeset) 19 Oct 2021 4:23PM $0.049 $0.015 fallen by 70.41%
$23 Notice of Annual General Meeting/Proxy Form 19 Oct 2021 4:19PM $0.049 $0.015 fallen by 70.41%
$23 Response to ASX Query Letter 14 Oct 2021 10:05AM $0.051 $0.015 fallen by 71.57%
$23 Provisional Patent Lodgements 14 Oct 2021 10:05AM $0.051 $0.015 fallen by 71.57%
$23 Trading Halt 12 Oct 2021 9:15AM $0.051 $0.015 fallen by 71.57%
$23 ASX Listing Rule 3.13.1 Notice Regarding AGM 29 Sep 2021 4:54PM $0.050 $0.015 fallen by 71%
$23 NTI164 Clinical Program Update 23 Sep 2021 8:38AM $0.039 $0.015 fallen by 62.82%
$23 IRD Invest Conference - Webinar Presentation 21 Sep 2021 8:22AM $0.042 $0.015 fallen by 65.48%
$23 Ceasing to be a substantial holder 14 Sep 2021 11:12AM $0.046 $0.015 fallen by 68.48%
$23 Appendix 4G and Corporate Governance Statement 30 Aug 2021 8:07AM $0.050 $0.015 fallen by 71%
$23 Appendix 4E and Annual Report 30 Aug 2021 8:06AM $0.050 $0.015 fallen by 71%
$23 Investor Webinar Presentation 5 Aug 2021 9:29AM $0.050 $0.015 fallen by 71%
$23 Investor Presentation 5 Aug 2021 9:29AM $0.050 $0.015 fallen by 71%
$23 Quarterly Report and Appendix 4C 30 Jul 2021 8:18AM $0.051 $0.015 fallen by 71.57%
$23 Phase I/II Clinical Trial Update 21 Jul 2021 9:27AM $0.055 $0.015 fallen by 73.64%

351 - 375 of 694 results

Page 15 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.